Sander Slootweg emphasizes the importance of investor confidence, stating, "With greater levels of capital, we can extend more support to our portfolio companies as they grow and seek to maximize their potential." This highlights the firms' commitment to nurturing innovative biotechs in vital medical sectors.
Robbert van de Griendt reflects on the successful fundraising amid market volatility, noting, "The strong demand...is directly related to our strong and consistent historical returns...and reflects investors' conviction in our specialist investment strategy." His remarks illustrate the firm's enduring appeal and market positioning.
Collection
[
|
...
]